Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Eugene Han; Ji Hye Huh; Eun Y Lee; Ji C Bae; Sung W Chun; Sung H Yu; Soo H Kwak; Kyong S Park; Byung-Wan Lee

doi:10.1111/dom.14623

YUHSpace

BROWSE

0 424

Cited 4 times in

Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Authors: Eugene Han ; Ji Hye Huh ; Eun Y Lee ; Ji C Bae ; Sung W Chun ; Sung H Yu ; Soo H Kwak ; Kyong S Park ; Byung-Wan Lee

Citation: DIABETES OBESITY & METABOLISM, Vol.24(4) : 752-756, 2022-04

Journal Title: DIABETES OBESITY & METABOLISM

ISSN: 1462-8902

Issue Date: 2022-04

MeSH: Diabetes Mellitus, Type 2* / complications ; Diabetes Mellitus, Type 2* / drug therapy ; Dipeptidyl-Peptidase IV Inhibitors* / adverse effects ; Double-Blind Method ; Humans ; Liver ; Non-alcoholic Fatty Liver Disease* / complications ; Non-alcoholic Fatty Liver Disease* / drug therapy ; Piperazines

Keywords: dipeptidyl peptidase-4 inhibitor ; evogliptin ; magnetic resonance imaging-derived proton density fat fraction ; non-alcoholic fatty liver disease ; pioglitazone ; type 2 diabetes

Full Text: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14623

DOI: 10.1111/dom.14623

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Lee, Byung Wan(이병완) https://orcid.org/0000-0002-9899-4992

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

YUHSpace

BROWSE

Browse

Links